Skip to main navigation Skip to search Skip to main content

SARS CoV-2 infection among patients using immunomodulatory therapies

  • Kevin L. Winthrop
  • , Amanda E. Brunton
  • , Susan Beekmann
  • , Philip Polgreen
  • , John Baddley
  • , Kenneth G. Saag
  • , Cassandra Calabrese
  • , Leonard Calabrese
  • , Philip C. Robinson
  • , Zachary S. Wallace
  • , Jeffrey R. Curtis

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)269-271
Number of pages3
JournalAnnals of the rheumatic diseases
Volume80
Issue number2
DOIs
StatePublished - Feb 1 2021

Funding

Funding This publication was supported by Cooperative Agreement Number 1 U50 CK00477 funded by the Centers for Disease Control and Prevention, and by Award Number UL1TR002537 funded by the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The author thanks Teresa Xu for supporting the development of this report by assisting with literature search and formatting.

FundersFunder number
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health
Centers for Disease Control and Prevention for fall prevention
National Center for Advancing Translational SciencesUL1TR002537

    Keywords

    • arthritis
    • autoimmune diseases
    • biological therapy
    • rheumatoid

    ASJC Scopus subject areas

    • Rheumatology
    • Immunology and Allergy
    • Immunology
    • General Biochemistry, Genetics and Molecular Biology

    Cite this